Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- ‘Tsunami of effort’ brings biologics to the forefront in giant cell arteritis, PMR Rob Volansky
-
- Rapid advances propel polymyalgia rheumatica care and research Leonard H. Calabrese, DO
- ACR recommends triple therapy for lupus nephritis in new 2024 guidelines Rob Volansky
- CAR-NK cell approach achieves ‘efficacy, persistence and super safety’ in lupus Rob Volansky
- CD19 CAR-T therapy yields long-term benefits in lupus, myositis, systemic sclerosis Justin Cooper
- ‘Concerning finding’: Rheumatologists lack time for billing musculoskeletal ultrasound Justin Cooper
- Delayed methotrexate start improves pneumococcal vaccine response in rheumatoid arthritis Rob Volansky
- Elsubrutinib, upadacitinib combination lowers lupus activity through 104 weeks Justin Cooper
- Expert consensus: Sterile bone inflammation to be called ‘chronic non-bacterial osteitis’ Justin Cooper
-
- Ivarmacitinib curbs rheumatoid arthritis symptoms, improves function through 52 weeks Justin Cooper
- ‘Left behind’: Patients with lupus across African diaspora face barriers to care, research Rob Volansky
- Long term autoimmune, autoinflammatory disease risk significantly higher after COVID-19 Justin Cooper
- Medication-assisted weight loss boosts patient-reported outcomes in rheumatic disease Justin Cooper
- New ACR president: Pharmacy benefit managers, artificial intelligence ‘must be regulated’ Rob Volansky
- Patients with lupus, type 2 diabetes at lower risk for MACE, VTE with GLP-1 vs DPP4 drugs Justin Cooper
- Political advocacy, supporting women in rheumatology among top goals for ACR president Rob Volansky
- Potential Sjögren’s drugs may herald ‘paradigm shift’ to treating underlying processes Rob Volansky
-
- Rheumatology PAs more satisfied with job vs other specialties despite lower pay Justin Cooper
- Rising placebo response rates in rheumatoid arthritis trials mirror recruitment shifts Justin Cooper
- Uptake of Benlysta, Saphnelo signal ‘exciting time’ for ‘lupologists’ Rob Volansky